AIP
NMRA icon

Ameritas Investment Partners’s Neumora Therapeutics NMRA Stock Holding History

Ameritas Investment Partners’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,241
Closed -$8.24K – 3291
2025
Q1 		$8.24K Hold
8,241
– – ﹤0.01% 2877
2024
Q4 		$87.4K Hold
8,241
– – ﹤0.01% 1858
2024
Q3 		$109K Hold
8,241
– – ﹤0.01% 1719
2024
Q2 		$81K Buy
8,241
+6,701
+435% +$69.3K ﹤0.01% 1854
2024
Q1 		$21.2K Hold
1,540
– – ﹤0.01% 2545
2023
Q4 		$26.3K Buy
+1,540
New +$18.9K ﹤0.01% 2463

Other funds holding NMRA

SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Ameritas Investment Partners's NMRA Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Neumora Therapeutics (NMRA) in Q2 2025, closing a stake of 8,241 shares — an estimated $8.24K sold.

Ameritas Investment Partners first reported a position in NMRA in Q4 2023 and held it in 6 quarters. The position peaked at $109K in Q3 2024. 98 funds tracked by Wall St. Rank hold NMRA as of Q2 2025.

  • Ameritas Investment Partners reported no remaining Neumora Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 8,241 Neumora Therapeutics shares in Q2 2025, an estimated $8.24K.
  • Ameritas Investment Partners first reported a position in Neumora Therapeutics in Q4 2023 and held it in 6 quarters.
  • Ameritas Investment Partners's Neumora Therapeutics position peaked at $109K in Q3 2024.
  • 98 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.